Edgemond James's Form 4 filing
United Therapeutics Corp (UTHR) · filed Apr 28, 2026
- Accession no.
- 0001636178-26-000013
- Filed
- Apr 28, 2026
- Trade date
- Apr 27, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.69M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edgemond JamesCIK 0001636178 | Officer (CFO AND TREASURER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Common Stock | MOption exerciseAcquired | +10,000 | $135.42 | +$1,354,200 | 28,876 | Direct | |
| Apr 27, 2026 | Common Stock | SSaleDisposed | −1,716 | $565.85F2 | −$970,998.6 | 27,160 | Direct | |
| Apr 27, 2026 | Common Stock | SSaleDisposed | −1,449 | $566.73F3 | −$821,191.77 | 25,711 | Direct | |
| Apr 27, 2026 | Common Stock | SSaleDisposed | −919 | $567.81F4 | −$521,817.39 | 24,792 | Direct | |
| Apr 27, 2026 | Common Stock | SSaleDisposed | −1,107 | $569.01F5 | −$629,894.07 | 23,685 | Direct | |
| Apr 27, 2026 | Common Stock | SSaleDisposed | −2,405 | $570.05F6 | −$1,370,970.25 | 21,280 | Direct | |
| Apr 27, 2026 | Common Stock | SSaleDisposed | −1,755 | $571.10F7 | −$1,002,280.5 | 19,525 | Direct | |
| Apr 27, 2026 | Common Stock | SSaleDisposed | −649 | $571.92F8 | −$371,176.08 | 18,876 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 52,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $565.22 to $566.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $566.36 to $567.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $567.41 to $568.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $568.55 to $569.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $569.59 to $570.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $570.62 to $571.605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $571.62 to $572.415. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.